SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433 | -87.9% | 21,020 | -72.4% | 0.00% | -88.6% |
| Q2 2023 | $3,577 | +13.4% | 76,089 | +1.3% | 0.04% | +9.4% |
| Q1 2023 | $3,153 | +13.7% | 75,137 | +3.3% | 0.03% | +10.3% |
| Q4 2022 | $2,774 | -99.9% | 72,737 | -6.5% | 0.03% | -19.4% |
| Q3 2022 | $3,045,000 | -18.6% | 77,768 | -31.2% | 0.04% | 0.0% |
| Q1 2022 | $3,740,000 | -19.0% | 113,001 | +4.1% | 0.04% | -12.2% |
| Q4 2021 | $4,619,000 | +7.2% | 108,587 | +11.7% | 0.04% | +2.5% |
| Q3 2021 | $4,308,000 | +5.0% | 97,214 | +34.7% | 0.04% | +5.3% |
| Q2 2021 | $4,101,000 | -19.8% | 72,190 | +5.6% | 0.04% | -24.0% |
| Q1 2021 | $5,116,000 | -8.7% | 68,347 | +5.6% | 0.05% | -10.7% |
| Q4 2020 | $5,602,000 | +6414.0% | 64,752 | +4525.1% | 0.06% | +5500.0% |
| Q3 2020 | $86,000 | -97.3% | 1,400 | -93.9% | 0.00% | -97.4% |
| Q3 2019 | $3,204,000 | -30.5% | 22,841 | -9.3% | 0.04% | -30.4% |
| Q2 2019 | $4,612,000 | +15.1% | 25,190 | 0.0% | 0.06% | +12.0% |
| Q1 2019 | $4,006,000 | +60.3% | 25,190 | -3.5% | 0.05% | +47.1% |
| Q4 2018 | $2,499,000 | -30.6% | 26,092 | +2.4% | 0.03% | -20.9% |
| Q3 2018 | $3,599,000 | -12.4% | 25,480 | -3.0% | 0.04% | -12.2% |
| Q2 2018 | $4,110,000 | -8.2% | 26,260 | -5.5% | 0.05% | -9.3% |
| Q1 2018 | $4,477,000 | -12.8% | 27,794 | -10.8% | 0.05% | -10.0% |
| Q4 2017 | $5,135,000 | +130.3% | 31,176 | -12.9% | 0.06% | +122.2% |
| Q3 2017 | $2,230,000 | -14.6% | 35,793 | +9.2% | 0.03% | -18.2% |
| Q2 2017 | $2,610,000 | – | 32,776 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |